R&D
Cancer – dealing with the greatest health challenge of our time
February 4, 2016Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership
Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …
Daiichi Sankyo to expand access to clinical trial data
February 3, 2016Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency
Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
Is bioscience still getting lost in translation?
January 27, 2016Research and Development CASMI, Centre for Sustainable Medical Innovation, Professor Richard Barker, R&D, bioscience
After several years of anguish about pharmaceutical pipelines, R&D productivity seems to be picking up.New medicines and cell and gene …
Patient involvement ‘would improve medicines R&D’
January 15, 2016Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D
A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …
Analysts say pharma R&D returns challenged by drag of high costs
December 16, 2015Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts
The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
Pharma deals crucial to cutting R&D costs
December 16, 2015Research and Development GlobalData, R&D, drug development, pharma, research and development
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
Pharma companies warned on patent box changes
December 16, 2015Research and Development R&D, patent box, pharma, research and development, tax
Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …
The age of collaboration: why pharma companies now have to work together
December 9, 2015Research and Development R&D, co-operation, collaboration, pharma
It seems 2015 may be remembered as the year of the mega merger; the year when all records were broken …
Lilly pulls plug on basal insulin Peglispro
December 8, 2015Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure
Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …
Pharma company vows to plough profits back into R&D
November 30, 2015Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise
An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …
Challenges in oncology R&D – part 2
November 25, 2015Manufacturing and Production, Research and Development R&D, Takeda, oncology
Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
Governments and industry ‘combining to stall drug development’
November 9, 2015Research and Development, Sales and Marketing BMJ, R&D, drug development
Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …
Drugs later in development ‘winning the race to market’
November 4, 2015Research and Development R&D, drug approval, drug development, market exclusivity
Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …
Shire to acquire Dyax in $5.9 billion deal
November 2, 2015Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease
Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …
European Commission funds €23m project to develop HIV vaccine
November 2, 2015Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020
The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
